Biodegradable Intrascleral Implant of Triamcinolone Acetonide in Experimental Uveitis
Authors:
- 1 June 2009
- journal article
- research article
- Published by SAGE Publications in Journal of Ocular Pharmacology and Therapeutics
- Vol. 25 (3) , 201-208
Abstract
To evaluate the efficacy of a biodegradable intrascleral implant of triamcinolone acetonide (TA) in a rabbit model of experimental uveitis. A disc-shaped TA implant (1 x 3 mm, containing 6.4 mg of TA), which is made by poly(D,L-lactide) (PLA) and TA, was intrasclerally implanted into eight albino rabbits after a subcutaneous injection of tuberculin antigen. Control animals (n = 8) received sham devices. Uveitis was induced with an intravitreal injection of tuberculin antigen. To induce chronic inflammation, all eyes were reinjected with intravitreal antigen on day 14 and were observed for 1 month. Aqueous protein concentrations and cell counts were determined on days 7, 14, and 28. Inflammation of the anterior chamber (AC) and vitreous opacity were graded clinically and retinal functions were evaluated electroretinographically and histologically. Anterior chamber cells, flare, and vitreous opacity scores showed significantly less inflammation in treated eyes than in untreated eyes (P < 0.05). Quantitative analyses of aqueous cell counts and protein concentrations showed significant decreases in treated eyes (P < 0.05). Histopathologic examinations showed less severe inflammation and tissue disorganization in treated eyes. The biodegradable intrascleral TA implant was found to be effective at suppressing the inflammation induced by experimental uveitis in rabbits for at least 4 weeks.Keywords
This publication has 37 references indexed in Scilit:
- A novel design of one-side coated biodegradable intrascleral implant for the sustained release of triamcinolone acetonideEuropean Journal of Pharmaceutics and Biopharmaceutics, 2008
- Ocular Concentration after Subtenon and Intravitreal Injection of Triamcinolone Acetonide in RabbitsJournal of the Korean Ophthalmological Society, 2008
- Effects of Periocular Administration of Triamcinolone Acetonide on Leukocyte-Endothelium Interactions in the Ischemic RetinaInvestigative Ophthalmology & Visual Science, 2007
- Intravitreal Triamcinolone Acetonide Concentration After Subtenon InjectionAmerican Journal of Ophthalmology, 2006
- Biodegradable scleral implants as new triamcinolone acetonide delivery systemsInternational Journal of Pharmaceutics, 2006
- Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injectionAmerican Journal of Ophthalmology, 2004
- A review of evidence guiding the use of corticosteroids in the treatment of intraocular inflammationOcular Immunology and Inflammation, 2004
- Intraocular Tissue Distribution of Betamethasone after Intrascleral Administration Using a Non-biodegradable Sustained Drug Delivery DeviceInvestigative Ophthalmology & Visual Science, 2003
- Biodegradable Intrascleral Implant for Sustained Intraocular Delivery of Betamethasone PhosphateInvestigative Ophthalmology & Visual Science, 2003
- DEXAMETHASONE SUSTAINED DRUG DELIVERY IMPLANT FOR THE TREATMENT OF SEVERE UVEITISRetina, 2000